Myocardial and metabolic dysfunction in type 2 diabetic rats: Impact of ghrelin

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 1, 2012, Pages 99-111

  Hussein, Abdel Aziz M ^a   Abdel Aziz, Azza ^a   Gabr, Mahmoud ^b   Hemmaid, Kamel Z ^c  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c Zagazig University   (Egypt)

Author keywords

Cardiomyopathy; Ghrelin; Isolated heart; Rats; Type 2 DM

Indexed keywords

ACYL COENZYME A OXIDASE; CHOLESTEROL; GHRELIN; GLUCOSE; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ISOPRENALINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHENYLEPHRINE; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAT CONTENT; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART RATE; HOMEOSTASIS; INSULIN RESISTANCE; ISOLATED HEART; LIPID DIET; LIPID STORAGE; MALE; METABOLIC DISORDER; MYOCARDIAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ACYL-COA OXIDASE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CARNITINE O-PALMITOYLTRANSFERASE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; GHRELIN; GLUCOSE TRANSPORTER TYPE 4; HEART; HEART RATE; HYPERTROPHY; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

EID: 84855588454     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y11-103     Document Type: Article

References (45)

1. Baldanzi, G., Filigheddu, N., Cutrupi, S., Catapano, F., Bonissoni, S., Fubini, A., et al. 2002. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell Biol. 159(6): 1029-1037. doi:10.1083/ jcb.200207165.
2. Beckman, J.A., Creager, M.A., and Libby, P. 2002. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA, 287(19): 2570-2581. doi:10.1001/jama.287.19.2570.
3. Brandt, J.M., Djouadi, F., and Kelly, D.P. 1998. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor a. J. Biol. Chem. 273(37): 23786-23792. doi:10.1074/jbc.273. 37.23786.
4. Burcelin, R., Printz, R.L., Kande, J., Assan, R., Granner, D.K., and Girard, J. 1993. Regulation of glucose transporter and hexokinase II expression in tissues of diabetic rats. Am. J. Physiol. 265(3): E392-E401.
5. Camps, M., Castelló, A., Muñoz, P., Monfar, M., Testar, X., Palacín, M., and Zorzano, A. 1992. Effect of diabetes and fasting on GLUT4 (muscle/fat) glucose-transporter expression in insulinsensitive tissues. Biochem. J. 282(3): 765-772.
6. Canga, L., and Sterin-Borda, L. 1986. Hypersensitivity to methoxamine in atria isolated from streptozotocin-induced diabetic rats. Br. J. Pharmacol. 87(1): 157-165.
7. Davidson, M.B., and Goodner, C.J. 1966. Assay of insulin antagonism by serial incubation of paired rat hemidiaghragm. Diabetes, 15(6): 380-387.
8. Downing, S.E., Lee, J.C., and Fripp, R.R. 1983. Enhanced sensitivity of diabetic hearts to a-adrenoceptor stimulation. Am. J. Physiol. 245(5): H808-H813.
9. Eto, K., Ohya, Y., Nakamura, Y., Abe, I., and Fujishima, M. 2001. Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle. Eur. J. Pharmacol. 423(1): 1-7. doi:10. 1016/S0014-2999(01)01047-0.
10. Fang, Z.Y., Prins, J.B., and Marwick, T.H. 2004. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr. Rev. 25(4): 543-567. doi:10.1210/er.2003-0012.
11. Frascarelli, S., Ghelardoni, S., Ronca-Testoni, S., and Zucchi, R. 2003. Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart. Basic Res. Cardiol. 98(6): 401-405. doi:10.1007/s00395-003-0434-7.
12. Gando, S., Hattori, Y., Akaishi, Y., Nishihira, J., and Kanno, M. 1997. Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: Alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation. J. Pharmacol. Exp. Ther. 282(1): 475-484.
13. Garvey, W.T., Hardin, D., Juhaszova, M., and Dominguez, J.H. 1993. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am. J. Physiol. 264(3): H837-H844.
14. Ghigo, E., Broglio, F., Arvat, E., Maccario, M., Papotti, M., and Muccioli, G. 2005. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin. Endocrinol. (Oxf.), 62(1): 1-17.
15. Golfman, L.S., Wilson, C.R., Sharma, S., Burgmaier, M., Young, M. E., Guthrie, P.H., et al. 2005. Activation of PPARg enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats. Am. J. Physiol. Endocrinol. Metab. 289(2): E328-E336. doi:10.1152/ajpendo.00055.2005.
16. Gualillo, O., Lago, F., Gómez-Reino, J., Casanueva, F.F., and Dieguez, C. 2003. Ghrelin, a widespread hormone: insights into molecular and cellular regulation of its expression and mechanism of action. FEBS Lett. 552(2-3): 105-109. doi:10.1016/S0014-5793(03)00965-7.
17. ILAR (Institute of Laboratory Animal Resources). 1996. Guide for the Care and Use of Laboratory Animals. NIH Publication No. 85-23 (revised 1996). National Academy Press, Washington, D.C. Available from www.nap.edu/openbook.php?record_id=5140.
18. Irlbeck, M., and Zimmer, H.G. 1996. Functional responses of the left and right heart of diabetic rats to α- and β-adrenergic receptor stimulation. Diabetes Res. Clin. Pract. 31(Suppl.): S79-S86. doi:10.1016/0168-8227(96)01234-X.
19. Iwakura, H., Akamizu, T., Ariyasu, H., Irako, T., Hosoda, K., Nakao, K., and Kangawa, K. 2007. Effects of ghrelin administration on decreased growth hormone status in obese animals. Am. J. Physiol. Endocrinol. Metab. 293(3): E819-E825. doi:10.1152/ ajpendo.00681.2006.
20. Kannel, W.B., and McGee, D.L. 1979. Diabetes and cardiovascular disease. The Framingham study. JAMA, 241(19): 2035-2038. doi:10.1001/jama.241.19.2035.
21. Kitamura, T., Shimizu, T., Ohkawa, N., Oda, H., Ohtsuki, M., and Kishiro, M. 2010. Effects of ghrelin on growth and cardiac function in infants with congenital heart diseases. Pediatr. Int. 52 (3): 358-361. doi:10.1111/j.1442-200X.2009.02966.x.
22. Kleinz, M.J., Maguire, J.J., Skepper, J.N., and Davenport, A.P. 2006. Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc. Res. 69(1): 227-235. doi:10.1016/j.cardiores.2005.09. 001.
23. Kohda, Y., Shirakawa, H., Yamane, K., Otsuka, K., Kono, T., Terasaki, F., and Tanaka, T. 2008. Prevention of incipient diabetic cardiomyopathy by high-dose thiamine. J. Toxicol. Sci. 33(4): 459-472. doi:10.2131/jts.33.459.
24. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., and Kangawa, K. 1999. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402(6762): 656-660. doi:10.1038/45230.
25. Li, W.G., Gavrila, D., Liu, X., Wang, L., Gunnlaugsson, S., Stoll, L. L., et al. 2004. Ghrelin inhibits proinflammatory responses and nuclear factor-k B activation in human endothelial cells. Circulation, 109(18): 2221-2226. doi:10.1161/01.CIR.0000127956. 43874.F2.
26. Liedtke, A.J., DeMaison, L., Eggleston, A.M., Cohen, L.M., and Nellis, S.H. 1988. Changes in substrate metabolism and effects of excess fatty acids in reperfused Myocardium. Circ. Res. 62(3): 535-542.
27. Livak, K.J., and Schmittgen, T.D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC (t)). Methods, 25(4): 402-408. doi:10.1006/meth.2001.1262.
28. Lopez, I.P., Milagro, F.I., Marti, A., Moreno-Aliaga, M.J., Martinez, J.A., and De Miguel, C. 2005. High-fat feeding period affects gene expression in rat white adipose tissue. Mol. Cell. Biochem. 275(1-2): 109-115. doi:10.1007/s11010-005-1082-z.
29. Maebuchi, M., Machidori, M., Urade, R., Ogawa, T., and Moriyama, T. 2003. Low resistin levels in adipose tissues and serum in highfat fed mice and genetically obese mice: development of an ELISA system for quantification of resistin. Arch. Biochem. Biophys. 416 (2): 164-170. doi:10.1016/S0003-9861(03)00279-0.
30. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., and Turner, R.C. 1985. Homeostasis model assessment: insulin resistance and [b]-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7): 412-419. doi:10.1007/BF00280883.
31. Nagaya, N., Uematsu, M., Kojima, M., Ikeda, Y., Yoshihara, F., Shimizu, W., et al. 2001. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation, 104(12): 1430-1435. doi:10.1161/hc3601.095575.
32. Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., and Matsukura, S. 2001. A role for ghrelin in the central regulation of feeding. Nature, 409(6817): 194-198. doi:10. 1038/35051587.
33. Regan, T.J., Wu, C.F., Yeh, C.K., Oldewurtel, H.A., and Haider, B. 1981. Myocardial composition and function in diabetes: the effect of chronic insulin use. Circ. Res. 49(6): 1268-1277.
34. Regan, T.J., Lyons, M.M., Ahmed, S.S., Levinson, G.E., Oldewurtel, H.A., Ahmad, M.R., and Haider, B. 1977. Evidence for cardiomyopathy in familial diabetes mellitus. J. Clin. Invest. 60 (4): 884-899. doi:10.1172/JCI108843.
35. Rossi, F., Bertone, C., Petricca, S., and Santiemma, V. 2007. Ghrelin inhibits angiotensin II-induced migration of human aortic endothelial cells. Atherosclerosis, 192(2): 291-297. doi:10.1016/ j.atherosclerosis.2006.07.021.
36. Rubler, S., Dlugash, J., Yuceoglu, Y.Z., Kumral, T., Branwood, A.W., and Grishman, A. 1972. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am. J. Cardiol. 30(6): 595-602. doi:10.1016/0002-9149(72)90595-4.
37. Shimoni, Y., Ewart, H.S., and Severson, D. 1998. Type I and II models of diabetes produce different modifications of K currents in rat heart: role of insulin. J. Physiol. 507(2): 485-496. doi:10. 1111/j.1469-7793.1998.485bt.x.
38. Sun, Y., Asnicar, M., Saha, P., Chan, L., and Smith, R. 2006. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab. 3(5): 379-386. doi:10.1016/j.cmet. 2006.04.004.
39. Taegtmeyer, H., McNulty, P., and Young, M.E. 2002. Adaptation and maladaptation of the heart in diabetes. Part I: general concepts. Circulation, 105(14): 1727-1733. doi:10.1161/01.CIR. 0000012466.50373.E8.
40. Unger, R.H. 2002. Lipotoxic diseases. Annu. Rev. Med. 53(1): 319-336. doi:10.1146/annurev.med.53.082901.104057.
41. Xu, Z., Wu, W., Zhang, X., and Liu, G. 2007. Endogenous ghrelin increases in adriamycin-induced heart failure rats. J. Endocrinol. Invest. 30(2): 117-125.
42. Yildirim, S., Sundler, F., and Bolkent, S. 2007. Ghrelin and insulin gene expression changes in streptozotocin-induced diabetic rats after rosiglitazone pretreatment. Eur. J. Histochem. 51(1): 11-18.
43. Young, M.E., Goodwin, G.W., Ying, J., Guthrie, P., Wilson, C.R., Laws, F.A., and Taegtmeyer, H. 2001. Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids. Am. J. Physiol. Endocrinol. Metab. 280(3): E471-E479.
44. Young, M.E., Guthrie, P.H., Razeghi, P., Leighton, B., Abbasi, S., Patil, S., et al. 2002. Impaired long chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes, 51 (8): 2587-2595. doi:10.2337/diabetes.51.8.2587.
45. Özüari, A., Öztürk, Y., Yildizoǧlu-Ari, N., Özçelikay, A.T., and Altan, V.M. 1993. The effects of glyburide and insulin on the cardiac performance in rats with non-insulin dependent diabetes mellitus. Gen. Pharmacol. 24(1): 165-169. doi:10.1016/0306-3623(93)90029-W.